Evidence Based HRT Treatment Options: A 2026 Guide

The Hot Flush Files
12 October 2026 · 7 mins · YOUR UNPAUSE POSSE

Table of Contents

Last Updated: October 21, 2026

What Evidence Based HRT Treatment Options Actually Involve

Evidence based HRT treatment options are hormone therapies chosen and prescribed according to the best available clinical research, matched to your symptoms, history and risk profile. At UnPause, our AHPRA-registered doctors work through those options with you in a 45-minute video consultation rather than handing over a script and moving on.

The landscape has shifted. For years, many women were told hormone therapy was too risky to bother with. Current thinking is more nuanced: for moderate-to-severe vasomotor symptoms in otherwise healthy women around the transition, menopausal hormone therapy (MHT) remains the most effective treatment we have.

Below, we break down every mainstream option, the evidence behind each, and the practical questions that decide which one suits you.

The terminology: MHT, HRT and body-identical hormones

Menopausal hormone therapy (MHT) is the current clinical term for what most people still call hormone replacement therapy (HRT). The two mean the same thing, and you'll see both used across Australian clinics and health.gov.au.

Body-identical hormones are hormones chemically identical to those your body produces, such as micronised progesterone and estradiol. They are not the same as compounded "bioidentical" products made by individual pharmacies, which the Therapeutic Goods Administration has not approved as standard treatments.

Who may be a candidate for treatment

You may be a candidate for MHT if you're experiencing moderate-to-severe menopausal symptoms, particularly hot flushes and night sweats, that interfere with sleep, work or mood.

Candidacy isn't automatic. Your doctor will weigh symptom severity, cardiovascular and breast cancer risk, history of blood clots, migraine, and your personal preferences. This is exactly the conversation UnPause's doctors are trained to have, and it's why we book 45 minutes rather than ten.

Comparing the Options: Oestrogen, Progesterone and Combined Therapy

Three regimens cover the vast majority of prescriptions: estrogen-only therapy, combined estrogen-plus-progestogen therapy, and local vaginal estrogen. The table below summarises how they compare.

Regimen Who it suits Key benefit Main consideration
Estrogen-only Women who have had a hysterectomy Relieves vasomotor symptoms No endometrial protection needed
Combined therapy Women with a uterus Symptom relief plus uterine protection Progestogen required for endometrial safety
Local vaginal estrogen Genitourinary symptoms Targeted relief for dryness and discomfort Minimal systemic absorption
Non-hormonal Those who can't or won't use hormones Reduces hot flushes in some women Generally less effective than estrogen

Estrogen-only therapy versus combined hormone therapy

The deciding factor is your uterus. If you've had a hysterectomy, estrogen-only therapy is usually appropriate. If you still have a uterus, you need a progestogen alongside estrogen to protect the endometrial lining, which is why combined hormone therapy is standard for most women.

Micronised progesterone and other progestogens

Progestogens come in several forms. Micronised progesterone is body-identical and taken orally, and many women report better tolerance, particularly for sleep and mood. Dydrogesterone is a well-studied synthetic option. Older synthetic progestogens remain effective but may carry different risk profiles. Your doctor will match the choice to your history.

Menopausal Hormone Therapy Benefits and Risks, Explained Plainly

The benefits of MHT are well documented for the right candidate: fewer and less severe hot flushes, better sleep, improved mood and, for many women, restored quality of life. Estrogen also protects bone density, which matters as fracture risk climbs after menopause.

Risks deserve plain language rather than scare tactics, and the most useful way to understand them is in absolute terms rather than relative ones.

What the evidence actually shows

  • Vasomotor symptoms: MHT is the most effective treatment for hot flushes and night sweats, with benefit seen across randomised trials and consistent across formulations.
  • Bone health: Estrogen reduces bone loss and fracture risk, and this benefit is well established.
  • Breast cancer: Combined estrogen-plus-progestogen therapy is associated with a small increase in breast cancer risk that rises with duration of use. Estrogen-only therapy does not show the same association in the largest observational studies. The absolute increase for a woman in her fifties on combined therapy for five years is small, but it is real and should be discussed.

The TGA publishes safety information on all registered hormone products, and your doctor should walk you through absolute numbers, not just relative ones. It is also worth knowing that much of the early alarm came from a large trial whose participants were older than the typical woman starting MHT today, which is why current guidance is more nuanced.

Key Takeaway The risk-benefit balance is individual, not universal. A woman with severe symptoms and no significant risk factors faces a very different calculation from one with a strong family history of breast cancer. Ask your doctor for the absolute numbers for your situation, not just the headline risk.

UnPause's doctors are trained to present these trade-offs clearly, and the UnPause Care app lets you log symptoms and side effects between appointments so your review is based on real data rather than memory.

Oral vs Transdermal HRT: Which Delivery Method Suits You

Delivery route matters more than most women are told. Oral estrogen passes through the liver first, which can affect clotting factors and triglycerides.

Oral therapy is simple and widely available. Transdermal suits women who want to minimise clot risk or who find tablets hard to tolerate. Neither is universally superior; the right choice depends on your risk profile and lifestyle.

Non-Hormonal Treatment for Hot Flushes and Night Sweats

Not everyone can or wants to use hormones, and for those women the evidence base for non-hormonal options has improved considerably. The key is knowing which options have solid trial support, which have modest support, and which are largely marketed on hope.

Prescription non-hormonal options

Several prescription medicines reduce vasomotor symptoms through different mechanisms:

Speak to an expert →

  • SSRIs and SNRIs (for example, certain antidepressants) lower hot flush frequency and severity. They are often used at lower doses than for mood, and benefit typically appears within a few weeks. Paroxetine and venlafaxine are among the more studied agents; your doctor will consider interactions with other medicines, particularly tamoxifen.
  • Gabapentin can reduce night sweats and is sometimes chosen when sleep disruption is prominent, though sedation and dizziness are common considerations.
  • Clonidine is an older option with modest benefit and a higher side-effect burden, so it is generally a later-line choice.

These medicines are not equivalent to estrogen for symptom relief, but for women with a history of breast cancer, a contraindication to hormones, or a strong personal preference against MHT, they can meaningfully improve quality of life. Your UnPause doctor can discuss whether a non-hormonal prescription is appropriate and how it fits alongside any other medicines you take.

Complementary and alternative approaches

Evidence here is mixed and generally weaker than for hormonal therapy, and product quality varies widely because supplements are not evaluated by the Therapeutic Goods Administration in the same way as registered prescription medicines.

  • Black cohosh has some trial support for hot flushes, but results are inconsistent and liver safety has been questioned in rare cases.
  • Phytoestrogens and red clover isoflavones show small effects in some studies, with benefit often difficult to distinguish from placebo.
  • Acupuncture and cognitive behavioural therapy (CBT) have modest evidence; CBT in particular has good support for helping women cope with hot flushes and sleep disruption, even if it does not reduce the flushes themselves.

Discuss any supplement with your doctor before starting, particularly if you take other medication or have liver or thyroid conditions.

Key Takeaway Non-hormonal options are not a consolation prize. For the right woman, a well-chosen prescription non-hormonal medicine plus practical strategies can deliver meaningful relief, and UnPause's doctors can help you weigh that against hormonal therapy.

How to Talk to Your Doctor About HRT

A woman in her forties sitting at a kitchen table with a notepad and laptop, preparing questions before a telehealth video call with a doctor on screen

Walking in prepared changes the conversation. Bring a written symptom log covering frequency, severity and timing of hot flushes, night sweats, sleep disruption and mood changes.

Ask direct questions:

  • Which regimen suits my history, and why?
  • What are my absolute risks on this treatment?
  • How will we monitor and review it?

If you've felt dismissed before, that's a signal to change doctor, not to give up. UnPause's team includes AHPRA-registered doctors who prioritise shared decision-making. You can read more about our clinical team and their qualifications before you book.

Pro Tip Record your consultation if your doctor agrees. Menopause appointments cover a lot of ground, and revisiting the advice later beats relying on memory.

Starting, Reviewing and Stopping HRT Treatment Options

Most women start on a low dose and adjust after six to twelve weeks based on symptom response. Review appointments are where the real fine-tuning happens: dose changes, swapping delivery route, or adding local vaginal estrogen for genitourinary symptoms.

Stopping is a decision to make with your doctor, not abruptly. Some women taper after a few years; others continue longer based on symptoms and risk. There's no fixed expiry date on treatment, and the right duration is individual.

Watch Out Stopping HRT abruptly can bring symptoms back quickly and make sleep and mood harder to manage. Plan a review before you stop.

Conclusion

Choosing among evidence based HRT treatment options shouldn't feel like guesswork. It should feel like a structured conversation with a doctor who knows your history and explains the trade-offs clearly.

UnPause exists for exactly that. Our AHPRA-registered doctors offer 45-minute video consultations, personalised MHT plans, Medicare rebates, and ongoing support through the UnPause Care app so you're not left alone between appointments.

Frequently Asked Questions

How effective is HRT for hot flushes and night sweats?

For moderate-to-severe vasomotor symptoms, menopausal hormone therapy is the most effective treatment available, and clinical guidelines position it as first-line therapy for suitable candidates. Many women notice improvement within a few weeks of starting, though the full effect can take up to three months. Response varies with dose, formulation and how you absorb it, which is why a review period matters. If symptoms persist at your check-in, your doctor can adjust the dose or switch delivery method. UnPause doctors build that review into your plan rather than leaving you to guess.

What are the non-hormonal treatment for hot flushes options?

Non-hormonal treatment for hot flushes includes prescription options such as certain antidepressants and other medicines used off-label for vasomotor symptoms, plus lifestyle measures like cooling strategies, reducing alcohol and managing stress. Some women try black cohosh, phytoestrogens or red clover, though evidence for these is mixed and product quality varies. Non-hormonal options are worth discussing if hormone therapy is unsuitable for you or you prefer to avoid it. Your doctor should explain expected benefit, side effects and how long to trial each option before judging whether it works.

What are the risks and benefits of menopausal hormone therapy?

Benefits include relief of hot flushes, night sweats, sleep disruption and mood symptoms, plus protection against bone loss for eligible women. Risks depend on the regimen: combined therapy with estrogen plus a progestogen carries a small increased breast cancer risk that rises with duration of use, while estrogen-only therapy does not carry the same breast cancer association. Transdermal estrogen is often preferred where cardiovascular or clot risk is a concern. Absolute risks are small for most women aged 50 to 59, and the risk-benefit balance should be assessed individually.

What are the risks associated with oral and transdermal HRT?

Oral estrogen passes through the liver first, which can raise clotting factors and triglycerides and affect blood pressure in some women. Transdermal estrogen, delivered by patch or gel, avoids that first-pass effect and is often recommended for women with risk factors such as obesity, migraines or a family history of clots. Both routes are effective for symptom relief. Skin irritation is the most common transdermal complaint. Your doctor should match the route to your history rather than defaulting to one option for everyone.

How do I know which HRT option may suit me?

The right option depends on whether you still have a uterus, your age and time since menopause, your symptom profile, your medical and family history, and your preferences about delivery method. Women with a uterus need a progestogen alongside estrogen to protect the uterine lining. Body-identical micronised progesterone is one option. If you have genitourinary symptoms, local vaginal estrogen may be added. A proper consultation reviews all of this. UnPause's AHPRA-registered doctors run 45-minute video appointments to work through it with you.

How long can you take HRT?

There is no fixed cutoff. Duration should be reviewed at least annually, weighing ongoing symptom relief against your personal risk profile. Many women use hormone therapy for several years through the menopause transition, and some continue longer after a documented discussion of benefits and risks. If you want to stop, your doctor can help you taper rather than cease abruptly, which reduces symptom rebound. Bone health, breast screening status and cardiovascular risk all feed into that review conversation.

What should I ask my doctor before starting HRT?

Ask which regimen suits your uterus status, whether oral or transdermal delivery is better for your history, what the absolute risks are for someone like you, how long to trial before reviewing, and what side effects to watch for. Bring a symptom log covering hot flushes, sleep, mood and cycle changes. Ask about Medicare rebates and follow-up support. UnPause patients can track symptoms in the UnPause Care app between appointments, so reviews are based on real patterns rather than memory.


References

  • Therapeutic Goods Administration: tga.gov.au
  • Australian Government Department of Health and Aged Care: health.gov.au
  • Services Australia (Medicare): servicesaustralia.gov.au
  • UnPause clinical resources: unpause.com.au

Talk to a doctor who gets it.

Book your UnPause consult, today.

Book your consult →

Ready to feel like yourself again?

Appointments available. Medicare rebate applies.

Book a Consult

Telehealth Australia-wide · Medicare rebate eligible